Kamada Ltd.
A biopharmaceutical company specializing in plasma-derived protein therapeutics.
KMDA | TA
Overview
Corporate Details
- ISIN(s):
- IL0010941198
- LEI:
- Country:
- Israel
- Address:
- 2 Holzman St, Science Park, 7670402 Rehovot
- Website:
- https://www.kamada.com
- Sector:
- Manufacturing
Description
Kamada Ltd. is a vertically integrated global biopharmaceutical company specializing in plasma-derived protein therapeutics. The company develops, manufactures, and commercializes a portfolio of products for rare and serious conditions, with a focus on therapeutic areas such as Alpha-1 Antitrypsin Deficiency (AATD) and Cytomegalovirus (CMV) prevention in transplant patients. Kamada utilizes a proprietary platform technology for advanced protein extraction and purification from human plasma. In addition to its marketed products, the company maintains a development pipeline of new therapies, including an inhaled treatment for AATD.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-23 16:12 |
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON DECEMBER 10, 202…
|
English | 523.5 KB | ||
| 2025-10-23 16:12 |
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON DECEMBER 10, 202…
|
English | 192.1 KB | ||
| 2025-10-23 16:04 |
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON DECEMBER 10, 202…
|
English | 523.5 KB | ||
| 2025-10-23 16:04 |
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON DECEMBER 10, 202…
|
English | 36.4 KB | ||
| 2025-09-02 16:03 |
Kamada to Participate in Upcoming September Investor Conferences
|
English | 135.5 KB | ||
| 2025-09-02 16:03 |
Kamada to Participate in Upcoming September Investor Conferences
|
English | 36.3 KB | ||
| 2025-08-13 16:00 |
Second Quarter and First Half 2025 Financial Results
|
English | 4.1 MB | ||
| 2025-08-13 16:00 |
Second Quarter and First Half 2025 Financial Results
|
English | 36.8 KB | ||
| 2025-08-11 16:00 |
FDA Approval of its Plasma Collection Center in Houston, Texas
|
English | 184.4 KB | ||
| 2025-08-11 16:00 |
FDA Approval of its Plasma Collection Center in Houston, Texas
|
English | 36.5 KB | ||
| 2025-08-06 16:05 |
to Announce Second Quarter and First Half Ended June 30, 2025, Financial Result…
|
English | 155.6 KB | ||
| 2025-08-06 16:05 |
to Announce Second Quarter and First Half Ended June 30, 2025, Financial Result…
|
English | 36.5 KB | ||
| 2025-08-05 17:33 |
Due to an error, trade halt was initiated in KAMADA's shares instead of CAMTEK'…
|
Hebrew (modern) | 62.0 KB | ||
| 2025-06-17 16:00 |
Kamada Confirms Continuous Global Business Operations and Products Availability…
|
English | 134.2 KB | ||
| 2025-06-17 16:00 |
Kamada Confirms Continuous Global Business Operations and Products Availability…
|
English | 36.6 KB |
Automate Your Workflow. Get a real-time feed of all Kamada Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Kamada Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Kamada Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
